Your browser doesn't support javascript.
loading
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.
Schmidl, Christian; Vladimer, Gregory I; Rendeiro, André F; Schnabl, Susanne; Krausgruber, Thomas; Taubert, Christina; Krall, Nikolaus; Pemovska, Tea; Araghi, Mohammad; Snijder, Berend; Hubmann, Rainer; Ringler, Anna; Runggatscher, Kathrin; Demirtas, Dita; de la Fuente, Oscar Lopez; Hilgarth, Martin; Skrabs, Cathrin; Porpaczy, Edit; Gruber, Michaela; Hoermann, Gregor; Kubicek, Stefan; Staber, Philipp B; Shehata, Medhat; Superti-Furga, Giulio; Jäger, Ulrich; Bock, Christoph.
Afiliación
  • Schmidl C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Vladimer GI; Regensburg Centre for Interventional Immunology and University Medical Center of Regensburg, Regensburg, Germany.
  • Rendeiro AF; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Schnabl S; Allcyte GmbH, Vienna, Austria.
  • Krausgruber T; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Taubert C; Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Krall N; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Pemovska T; Allcyte GmbH, Vienna, Austria.
  • Araghi M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Snijder B; Allcyte GmbH, Vienna, Austria.
  • Hubmann R; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Ringler A; Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Runggatscher K; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Demirtas D; Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.
  • de la Fuente OL; Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Hilgarth M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Skrabs C; Christian Doppler Laboratory for Chemical Epigenetics and Anti-Infectives, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Porpaczy E; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Gruber M; Christian Doppler Laboratory for Chemical Epigenetics and Anti-Infectives, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Hoermann G; Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Kubicek S; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Staber PB; Allcyte GmbH, Vienna, Austria.
  • Shehata M; Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Superti-Furga G; Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Jäger U; Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Nat Chem Biol ; 15(3): 232-240, 2019 03.
Article en En | MEDLINE | ID: mdl-30692684
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Agammaglobulinemia Tirosina Quinasa Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Chem Biol Asunto de la revista: BIOLOGIA / QUIMICA Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Agammaglobulinemia Tirosina Quinasa Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Chem Biol Asunto de la revista: BIOLOGIA / QUIMICA Año: 2019 Tipo del documento: Article